Login / Signup
The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients.
Chien-Wei Peng
Wen-Juei Jeng
Published in:
Hepatology international (2021)
Keyphrases
</>
hepatitis b virus
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
stem cells
patient reported outcomes
bone marrow